propentofylline has been researched along with Glioblastoma in 3 studies
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhruv, HD | 1 |
| Roos, A | 1 |
| Tomboc, PJ | 1 |
| Tuncali, S | 1 |
| Chavez, A | 1 |
| Mathews, I | 1 |
| Berens, ME | 1 |
| Loftus, JC | 1 |
| Tran, NL | 1 |
| Jacobs, VL | 2 |
| Landry, RP | 1 |
| Liu, Y | 2 |
| Romero-Sandoval, EA | 1 |
| De Leo, JA | 2 |
3 other studies available for propentofylline and Glioblastoma
| Article | Year |
|---|---|
Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
Topics: Apoptosis; Blotting, Western; Brain Neoplasms; Cell Proliferation; Gene Expression Regulation, Neopl | 2016 |
Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Central Nervous System; Disease Models, Animal; Gli | 2012 |
Propentofylline targets TROY, a novel microglial signaling pathway.
Topics: Animals; Blotting, Western; Cell Movement; Flow Cytometry; Focal Adhesion Kinase 2; Glioblastoma; Im | 2012 |